Cancer Control Emphasis Shift to Prevention Projected For Y 1978; Advisors Seek More
In Brief: NCI Gets $867 Million From Conferees; Grants To Be Funded At 41-42% Including Some Holdovers
New Mammography Guidelines Cut Uses By Women Under 50 t 25%
White House Says Upton Appointment Due In Two Weeks
New SEER RFP Sees cheaper Way To Get Data
Questions Raised By Committee Kills Still Not Resolved
ACS-Roosevelt Fellows Announced
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Blood Cancer United: A new name at the right moment
- With five-year cancer survival at an all-time high, does this mean people are living longer?
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer









